Policy | August 27, 2025
GST rejig may impact competitiveness of medical devices: AiMeD
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
AiMeD noted that proposed GST changes—to either 5% or 18%—both present significant risks requiring carefully nuanced consideration
The suite represents a multi-million-dollar investment in equipment upgrades and enhancements to improve the site's capabilities
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
With this addition, the company’s total Installed MCC Capacity will rise to 30,000 MTPA
The facility includes advanced laboratories to monitor market trends, consumer needs, product innovation, and formulation improvements
_256_384.jpg)
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus
FDA requests Sarepta Therapeutics to suspend distribution of Elevidys and places clinical trials on hold for multiple gene therapy products following 3 deaths
Acquisition to be followed by merger; strengthens Torrent’s IPM market presence
Changhua site meets international regulatory standards for global medical applications
The Swiss peptide and oligonucleotide manufacturers roll out major investments across site networks in US, UK and Switzerland
Subscribe To Our Newsletter & Stay Updated
